Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NEUROBLASTOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Not applicableApproved For MarketingNCT00730444
What this trial is testing

Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma

Who this might be right for
Neuroblastoma
GE Healthcare
Not applicableEnrolling By InvitationNCT06703944
What this trial is testing

Risk Model for Metastasis Detection of Neuroblastoma

Who this might be right for
Neuroblastoma (NB)PrognosisBone Marrow Metastasis+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)Looking for participantsNCT06450041
What this trial is testing

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 62
Not applicableStudy completedNCT01121419
What this trial is testing

The Role of IMP3 Expression in Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
National Taiwan University Hospital
Early research (Phase 1)Study completedNCT01208454
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

Who this might be right for
Localized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma+2 more
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT03236857
What this trial is testing

The Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Who this might be right for
MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more
AbbVie 143
Early research (Phase 1)Active Not RecruitingNCT04106219
What this trial is testing

LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Eli Lilly and Company 71
Testing effectiveness (Phase 2)WithdrawnNCT04909515
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

Who this might be right for
Neuroblastoma
Y-mAbs Therapeutics
Large-scale testing (Phase 3)Looking for participantsNCT03126916
What this trial is testing

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 750
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Testing effectiveness (Phase 2)Study completedNCT02395666
What this trial is testing

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Who this might be right for
Neuroblastoma
Giselle Sholler 140
Testing effectiveness (Phase 2)Study completedNCT01492673
What this trial is testing

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 9
Not applicableLooking for participantsNCT01109394
What this trial is testing

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Who this might be right for
SarcomaEndocrine TumorsNeuroblastoma+2 more
National Cancer Institute (NCI) 6,035
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Early research (Phase 1)Looking for participantsNCT03294954
What this trial is testing

GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma

Who this might be right for
Neuroblastoma
Baylor College of Medicine 70
Testing effectiveness (Phase 2)Study completedNCT00002634
What this trial is testing

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00960739
What this trial is testing

Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma

Who this might be right for
Neuroblastoma
Centre Oscar Lambret 30
Early research (Phase 1)Study completedNCT00083135
What this trial is testing

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 18
Next Page